Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
An inhalational anesthetic is a chemical which has properties of a general anesthetic which can be delivered by inhalation. Inhalation Anasthesia helps avoid excessive dosage and keeps the patient’s autonomic functions intact. In recent times, it has become the anesthetic of choice over Intravenous Anesthesia (IVA) among majority of healthcare practitioners owing to its benefits over general anaesthesia. These drugs are having lower chances of accumulation in the body as it gets eliminated via lungs. Drugs administered through inhaled route have limited tolerance and addiction level compared to alternatives routes. Anesthetists controls inhalation anesthesia through an anesthesia mask, tracheal tube or laryngeal mask airway connected to vaporizer and an anesthetic delivery system.
Constantly, increasing number of surgeries worldwide is one of the major factors driving growth of the inhalation anesthesia market. As indicated by “Global Surgery 2030 Evidence and Solutions for Achieving Health, Welfare, and Economic Development” report, the Lancet Commission on Global Surgery (LCoGS) highlighted that globally, 5 billion people do not have access to safe, affordable surgical and anaesthesia care when needed, and that between 28 percent and 32 percent of the global burden of disease requires surgical care, anaesthesia management or both. surgical conditions claim an estimated 16.9 million lives per year. Further, according to the World Health Organization, the number of surgical procedures performed in 2012 were 312.9 million as against 226.4 million in 2004, reflecting growth of 38.2%. Because of numbers like these, there is growing need of anesthesia worldwide, thus propelling the growth of the inhalation anesthesia market.
Increasing geriatric population prone to chronic diseases, growing demand for a lesser duration of hospitalization, the increasing number of emergency cases, including accident cases, emergency labor, etc., all over the world, are some of the other factors contributing to the growth of the market.
The report analyses the Inhalation Anesthesia Market based on drug type, end user and geography.
The inhalation anesthesia products include volatile nitrous oxide and halogenated agents. Halogeneted agents comprises of Sevoflurane, Desflurane, Isoflurane, Enflurane and Halothane. These products are used for induction and maintenance of anesthesia for patients during surgical products. Globally, sevoflurane is broadly used for anesthesia induction due to its therapeutic advantages and low cost. addition, other benefits include, low blood gas solubility permitting quick initiation of arrival from anesthesia, non-pungent odor, nominal respiratory and cardiovascular side effects, less effect on cerebral blood flow should boost segment growth. Desflurane and isoflurane are used based on patient requirements and the need for prolonged induction or maintenance of anesthesia. Isoflurane is anticipated to witness the lucrative growth over the forecast period, owing to its growing use in maintenance of anesthesia for treatment of weak or geriatric patients due to its sparing effect on cardiovascular function.
The major end user of the inhalation anesthesia include hospitals, ambulatory surgical centers, and others. Hospitals segment held the significant market share and anticipated to robust growth during the forecast period owing to the increase in the number of surgeries being performed at hospitals coupled with the availability of advanced healthcare facilities and increasing affordability of treatment due to the rising disposable income. The ambulatory surgical centers segment is anticipated to witness strong growth during the forecast period owing of low costs associated with the surgery as well as rapidly increasing immediate need in the facility for timely processes without long delays, thereby benefitting in expansion of customer-base.
Geographically, the global Inhalation Anesthesia Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is estimated to hold a significant share of the global market due to high adoption of technology and well-established health care infrastructure. Moreover, high number of surgeries performed in this region is likely to contribute to North America’s largest share of the market.
On the other hand, Asia Pacific is expected to expand at the fastest CAGR over the forecast period. Rise in medical tourism coupled with rapid penetration of insurance coverage will enable more people to opt for surgical products and is expected to significantly boost the usage of inhalation anesthetics. Other key factors contributing to the growth of the market include increasing population, availability of healthcare insurance for masses, public and private healthcare expenditure, and growing incidence of chronic diseases.
The key players operating the Inhalation Anesthesia Market globally are Baxter International, Inc.,AbbVie, Inc., Halocarbon Products Corporation, Hikma Pharmaceuticals, Piramal Healthcare, Lunan Pharmaceuticals, Mylan NV, Maruishi Pharmaceuticals Co. Ltd.Jiangsu Hengrui Medicine Co., LtdNeon Laboratories Ltd., Troikaa Pharmaceuticals Ltd.Piramal Enterprises Limited among others.
The report analyses the Inhalation Anesthesia Market based on drug type, end user and geography. The inhalation anesthesia products include volatile nitrous oxide and halogenated agents. Halogeneted agents comprises of Sevoflurane, Desflurane, Isoflurane, Enflurane and Halothane. The major end user of the inhalation anesthesia include hospitals, ambulatory surgical centers, and others. Geographically, the global Inhalation Anesthesia Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The key players operating the Inhalation Anesthesia Market globally are Baxter International, Inc.,AbbVie, Inc., Halocarbon Products Corporation, Hikma Pharmaceuticals, Piramal Healthcare, Lunan Pharmaceuticals, Mylan NV, Maruishi Pharmaceuticals Co. Ltd.Jiangsu Hengrui Medicine Co., LtdNeon Laboratories Ltd., Troikaa Pharmaceuticals Ltd.Piramal Enterprises Limited among others.
Why to buy this report:
